Assignee
ARBOR BIOTECHNOLOGIES INC
US·22 granted patents·49 pending applications·72 citations·filing 2018–2025
Top patents by PatentIndex Score
71 records- 0196US11667904B2CRISPR-associated systems and componentsARBOR BIOTECHNOLOGIES INC·Filed 2020·Granted Jun 6, 2023·6 cites·20 claims
- 0296US11447771B1CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2021·Granted Sep 20, 2022·3 cites·22 claims
- 0396US11168324B2Crispr DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2020·Granted Nov 9, 2021·5 cites·55 claims
- 0496US10808245B2CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2019·Granted Oct 20, 2020·28 cites·20 claims
- 0596US10392616B2CRISPR RNA targeting enzymes and systems and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2018·Granted Aug 27, 2019·18 cites·30 claims
- 0695US11912992B2CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Feb 27, 2024·2 cites·28 claims
- 0795US11643654B2Crispr DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted May 9, 2023·2 cites·22 claims
- 0895US11453867B2CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2021·Granted Sep 27, 2022·4 cites·23 claims
- 0993US11976308B2CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted May 7, 2024·1 cites·23 claims
- 1092US11795442B2CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Oct 24, 2023·1 cites·23 claims
- 1186US11168322B2CRISPR RNA targeting enzymes and systems and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2018·Granted Nov 9, 2021·2 cites·21 claims
- 1284US2024101990A1Crispr dna targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2023·Application pending·0 cites
- 1378US2024409908A1Novel crispr-associated transposon systems and componentsARBOR BIOTECHNOLOGIES INC·Filed 2024·Application pending·0 cites
- 1478US2023407281A1Novel crispr-associated systems and componentsARBOR BIOTECHNOLOGIES INC·Filed 2023·Application pending·0 cites
- 1577US2022098579A1Novel crispr dna targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1675US12460203B2CRISPR RNA targeting enzymes and systems and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Granted Nov 4, 2025·0 cites·21 claims
- 1775US11866746B2Compositions comprising a variant Cas12i4 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Jan 9, 2024·0 cites·20 claims
- 1874US2025154483A1Novel crispr dna and rna targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2024·Application pending·0 cites
- 1973US12460190B2CRISPR DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2020·Granted Nov 4, 2025·0 cites·25 claims
- 2073US11946045B2Compositions comprising a variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Apr 2, 2024·0 cites·23 claims
- 2172US11821012B2Gene editing systems comprising an RNA guide targeting hydroxyacid oxidase 1 (HAO1) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Nov 21, 2023·0 cites·22 claims
- 2272US2020407716A1Novel crispr dna targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 2372US2020407715A1Novel crispr dna targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 2470US12522812B2CRISPR-associated systems and componentsARBOR BIOTECHNOLOGIES INC·Filed 2019·Granted Jan 13, 2026·0 cites·18 claims
- 2568US11939607B2Gene editing systems comprising an RNA guide targeting lactate dehydrogenase a (LDHA) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Mar 26, 2024·0 cites·21 claims
- 2667US2023023791A1Gene editing systems comprising a crispr nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 2767US2024102007A1Gene editing systems comprising a crispr nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 2866US12553045B2Crispr DNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2018·Granted Feb 17, 2026·0 cites·23 claims
- 2966US12344870B2Compositions comprising a CRISPR nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Granted Jul 1, 2025·0 cites·20 claims
- 3065US12054754B2CRISPR-associated transposon systems and componentsARBOR BIOTECHNOLOGIES INC·Filed 2018·Granted Aug 6, 2024·0 cites·21 claims
- 3165US2025127924A1Gene editing systems comprising an rna guide targeting stathmin 2 (stmn2) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 3265US2024254494A1Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 3365US2023032141A1Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 3465US2023203539A1Gene editing systems comprising an rna guide targeting stathmin 2 (stmn2) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 3564US2024301447A1Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcriptARBOR BIOTECHNOLOGIES INC·Filed 2024·Application pending·0 cites
- 3663US2024309346A1Compositions comprising a variant cas12i4 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 3762US2023048564A1Crispr-associated transposon systems and methods of using sameARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 3861US2022396782A1Gene editing systems comprising an rna guide targeting transthyretin (ttr) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 3961US2024261435A1Gene editing systems comprising an rna guide targeting transthyretin (ttr) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 4061US2024141388A1Compositions comprising a variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 4160US12195770B2CRISPR DNA and RNA targeting enzymes and systemsARBOR BIOTECHNOLOGIES INC·Filed 2019·Granted Jan 14, 2025·0 cites·20 claims
- 4260US2025290053A1Compositions comprising a crispr nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2025·Application pending·0 cites
- 4360US2024093228A1Compositions comprising a nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 4459US2024035010A1Compositions comprising a variant polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2023·Application pending·0 cites
- 4558US2024011031A1Compositions comprising a nuclease and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 4657US2024011004A1Compositions comprising a variant crispr nuclease polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 4757US2024352434A1Compositions comprising a variant cas12i3 polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 4857US2023034581A1Gene editing systems comprising an rna guide targeting lactate dehydrogenase a (ldha) and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 4956US2023287456A1Compositions comprising a cas12i polypeptide and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 5056US2024301446A1Cas12i2 fusion molecules and uses thereofARBOR BIOTECHNOLOGIES INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ARBOR BIOTECHNOLOGIES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →